Novel discoveries targeting gemcitabine‐based chemoresistance and new therapies in pancreatic cancer: How far are we from the destination?

Pancreatic cancer (PC) remains one of the deadliest malignancies worldwide. Chemoresistance is a significant clinical problem in pancreatic ductal adenocarcinoma (PDAC) and numerous potential mechanisms have been demonstrated but much remains to be understood. To overcome the existing limitations in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer Med
Hauptverfasser: Luo, Wenhao, Yang, Gang, Qiu, Jiangdong, Luan, Jingyang, Zhang, Ying, You, Lei, Feng, Mengyu, Zhao, Fangyu, Liu, Yueze, Cao, Zhe, Zheng, Lianfang, Zhang, Taiping, Zhao, Yupei
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2019
Schlagworte:
Cancer Prevention
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6797580/
https://ncbi.nlm.nih.gov/pubmed/31475468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2384
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge